Press release
Metformin Market 2024 - By Size, Competitive Landscape, Upcoming Trends And Outlook By 2033
Metformin Market
As per the report, the metformin market size has grown strongly in recent years. It will grow from $3.91 billion in 2023 to $4.17 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The metformin market size is expected to see strong growth in the next few years. It will grow to $5.50 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16475&type=smp
Increasing Prevalence Of Diabetes Driving Growth Of The Metformin Market
The increasing prevalence of diabetes is expected to propel the growth of the metformin market going forward. Diabetes is a health issue that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it makes. The prevalence of diabetes is due to several factors, such as the obesity pandemic, genetic predispositions, lifestyle modifications, restricted access to healthcare, and exposure to particular toxins. Metformin assists in managing type 2 diabetes by lowering blood sugar, increasing weight loss, enhancing insulin sensitivity, and possibly providing other cardiovascular advantages. For instance, in December 2021, according to the International Diabetes Federation, a US-based intergovernmental organization, approximately 537 million adults aged 20-79 had diabetes in 2021, with numbers expected to rise to 643 million by 2030 and 783 million by 2045. Therefore, the increasing prevalence of diabetes is driving the growth of the metformin market.
Innovative Triple-Drug Fixed-Dose Combinations For Diabetes Management
Major companies operating in the metformin market are focusing on developing innovative diabetes medications, such as triple-drug FDC, to strengthen their position in the market. A triple-drug Fixed-Dose Combination (FDC) for diabetes medications typically refers to a single tablet or capsule combining three different antidiabetic medications. These combinations are designed to provide synergistic effects in managing blood sugar levels and improving overall glycemic control in patients with type 2 diabetes. For instance, in October 2023, Glenmark Pharmaceuticals, an India-based pharmaceutical company, launched the first triple-drug fixed-dose combination (FDC) of teneligliptin with dapagliflozin and metformin in India. This FDC, branded as Zita DM, contains teneligliptin (20 mg), dapagliflozin (10 mg), and metformin SR (500 mg/1000 mg) in a fixed dose. It is designed to improve glycemic control in adult patients with Type 2 diabetes, particularly those whose diabetes is uncontrolled by metformin or who require the addition of teneligliptin and dapagliflozin as separate drugs.
The metformin market covered in this report is segmented -
1) By Product Type: Standard-Release Tablets, Slow-Release Tablets
2) By Dosage Type: 500MG, 750MG, 850MG, 1G
3) By End-user: Clinics, Hospitals, Homecare, Other End-Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16475&type=discount
Major companies operating in the metformin market are Wockhardt Limited, Aarti Drugs, Abhilash Chemicals Private Limited, Farmhispania, Rochem International Inc., Jai Radhe Sales, Chr. Olesen Group, Aspire Lifesciences Pvt. Ltd., Ria Lifesciences Pvt. Ltd., Shree Sadguru, LGM Pharma, HRV Global Life Sciences, Octavius Pharma Pvt. Ltd., USV Private Limited, Zeon Pharma Industries India Pvt. Ltd., Atman Pharmaceuticals, Aastrid International Pvt. Ltd., Abhilasha Pharma, Anwita Drugs & Chemicals Pvt. Ltd., IOL Chemicals and Pharmaceuticals, Gangwal Healthcare, Granules India Limited, Alekhya Drugs Pvt. Ltd, Angels Pharma India Private Limited, Auro Laboratories Ltd.
Contents of the report:
1. Executive Summary
2. Metformin Market Report Structure
3. Metformin Market Trends And Strategies
4. Metformin Market - Macro Economic Scenario
5. Metformin Market Size And Growth
…..
27. Metformin Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/metformin-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metformin Market 2024 - By Size, Competitive Landscape, Upcoming Trends And Outlook By 2033 here
News-ID: 3618957 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Metformin
Metformin Drugs Market, Global Outlook and Forecast 2025-2032
As of 2023, the global Metformin Drugs market was valued at approximately USD 3,784 million. However, market projections indicate a decline, with the market expected to reach USD 2,252.68 million by 2032. This represents a negative compound annual growth rate (CAGR) of -0.06% over the forecast period. North America accounted for USD 893.62 million in 2023, with a projected CAGR of -0.05% through 2032. The downward trend in market valuation…
Key Influencer in the Metformin Market 2025: Increasing Prevalence Of Diabetes D …
What market dynamics are playing a key role in accelerating the growth of the metformin market?
The growing prevalence of diabetes is anticipated to boost the metformin market. Diabetes occurs when the pancreas produces insufficient insulin or the body cannot effectively use the insulin produced. Factors such as obesity, genetic predisposition, and lifestyle choices contribute to the rise in diabetes cases. Metformin helps control blood sugar, enhance insulin sensitivity, and promote…
Primary Catalyst Driving Metformin Market Outlook Evolution in 2025: Increasing …
What Is the Future Outlook for the Metformin Market's Size and Growth Rate?
In the past years, the market size of metformin has seen robust growth. The market is set to expand from $4.17 billion in 2024 to $4.48 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 7.4%. Factors driving past growth include a surge in diabetes cases, greater awareness towards diabetes and higher spending on…
The Metformin Market: A Cornerstone in Diabetes Care
Metformin, a first-line medication for type 2 diabetes, has been a cornerstone of diabetes management for decades. Its efficacy, safety, and affordability have made it a mainstay in treatment regimens worldwide. This post will delve into the metformin market, exploring its size, share, opportunities, challenges, demand, and trends.
Market Size and Share
The global metformin market is a significant segment of the diabetes therapeutics market. While precise figures can vary depending on…
Unlocking Potential: Metformin Hydrochloride Market Impact on Market Dynamics
The Metformin Hydrochloride Market 𝐑𝐞𝐩𝐨𝐫𝐭 dissects the complex fragments of the Market in an easy-to-read manner. This report covers drivers, restraints, challenges, and threats in the Metformin Hydrochloride Market to understand the overall scope of the Market in a detailed yet concise manner.
Additionally, the Market report covers the top-winning strategies implemented by major industry players and technological advancements that steer the growth of the Market.
𝐂𝐥𝐚𝐢𝐦 𝐲𝐨𝐮𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞…
Metformin Hydrochloride API Market: Lucrative Opportunities
Metformin Hydrochloride API Market: Introduction
According to the report, the global metformin hydrochloride API market was valued at ~US$ 300 Mn in 2020 and is projected to expand at a CAGR of ~5% from 2021 to 2031. Metformin hydrochloride is primarily used in the treatment of diabetes. The prevalence of diabetes is expected to increase across the world due to change in lifestyle and factors such as malnutrition and genetic mutations.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82470
According to government and private…
